Michael Herbert

Title: Michael Herbert - Innovator in Protective Antigen Research

Introduction

Michael Herbert is a notable inventor based in Great Britain, recognized for his contributions to the field of immunology. He has developed significant innovations related to protective antigens, particularly in the context of Bacillus anthracis, the bacterium responsible for anthrax. His work has implications for vaccine development and immune response enhancement.

Latest Patents

Michael Herbert holds a patent titled "Preparation Of Protective Antigen From Bacillus Anthracis." This patent describes a polynucleotide sequence that includes a nucleic acid sequence with at least 75% identity to SEQ ID NO: 1. The sequence encodes recombinant Bacillus anthracis Protective Antigen (rPA) or a fragment thereof. The invention also encompasses expression vectors and host cells that utilize this polynucleotide sequence, along with methods for producing rPA or its fragments. Additionally, it provides antigenic compositions and methods for inducing an immune response.

Career Highlights

Throughout his career, Michael Herbert has worked with prominent organizations, including Dynport Vaccine Company LLC and the Secretary of State for Health. His experience in these institutions has allowed him to contribute to significant advancements in vaccine technology and public health.

Collaborations

Michael has collaborated with notable professionals in his field, including John Brehm and Ian Mcentee. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.

Conclusion

Michael Herbert's innovative research in protective antigens showcases his commitment to advancing immunological science. His contributions are vital for the development of effective vaccines and enhancing immune responses against serious pathogens.